Baillie Gifford & Co’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-139,047
| Closed | -$172K | – | 267 |
|
|
2025
Q1 | $172K | Sell |
139,047
-151,382
| -52% | -$188K | ﹤0.01% | 250 |
|
|
2024
Q4 | $523K | Sell |
290,429
-403,510
| -58% | -$726K | ﹤0.01% | 249 |
|
|
2024
Q3 | $1.49M | Sell |
693,939
-13,691
| -2% | -$29.3K | ﹤0.01% | 245 |
|
|
2024
Q2 | $1.32M | Sell |
707,630
-119,618
| -14% | -$224K | ﹤0.01% | 250 |
|
|
2024
Q1 | $2.19M | Buy |
827,248
+10,605
| +1% | +$28.1K | ﹤0.01% | 247 |
|
|
2023
Q4 | $2.52M | Sell |
816,643
-347,366
| -30% | -$1.07M | ﹤0.01% | 251 |
|
|
2023
Q3 | $1.84M | Sell |
1,164,009
-254,987
| -18% | -$403K | ﹤0.01% | 254 |
|
|
2023
Q2 | $2.8M | Sell |
1,418,996
-220,900
| -13% | -$435K | ﹤0.01% | 248 |
|
|
2023
Q1 | $3.16M | Buy |
1,639,896
+1,040,000
| +173% | +$2.01M | ﹤0.01% | 249 |
|
|
2022
Q4 | $1.26M | Sell |
599,896
-188,941
| -24% | -$397K | ﹤0.01% | 268 |
|
|
2022
Q3 | $1.81M | Sell |
788,837
-92,095
| -10% | -$211K | ﹤0.01% | 262 |
|
|
2022
Q2 | $2.49M | Sell |
880,932
-201,163
| -19% | -$569K | ﹤0.01% | 261 |
|
|
2022
Q1 | $4.91M | Buy |
1,082,095
+2,584
| +0.2% | +$11.7K | ﹤0.01% | 252 |
|
|
2021
Q4 | $8.77M | Buy |
1,079,511
+2,986
| +0.3% | +$24.2K | ﹤0.01% | 250 |
|
|
2021
Q3 | $13.6M | Buy |
1,076,525
+42,653
| +4% | +$538K | 0.01% | 235 |
|
|
2021
Q2 | $16M | Buy |
+1,033,872
| New | +$16M | 0.01% | 235 |
|